Amy Parison - 08 Apr 2025 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
SVP, Chief Financial Officer
Signature
/s/ Amy Parison
Issuer symbol
EDIT
Transactions as of
08 Apr 2025
Net transactions value
$0
Form type
4
Filing time
08 Apr 2025, 16:29:42 UTC
Previous filing
08 Apr 2025
Next filing
04 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDIT Stock Option (right to buy) Award $0 +34,672 $0.000000 34,672 08 Apr 2025 Common Stock 34,672 $0.9800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on April 8, 2025 and is scheduled to vest over four years, with 25% of the shares to vest on April 8, 2026 and the remaining 75% of the shares scheduled to vest in equal monthly monthly installments thereafter through April 8, 2029.